Blast Targeting Military Train in Pakistan Could Heighten Security Concerns for Investors AI Economy Reshapes Job Market BlueCollar Skilled Trades Gain as WhiteCollar Entry Roles Slow Disneys The Mandalorian and Grogu Opens to 82 Million Marking a Low Point for Star Wars Franchise LIC and HDFC Bank Lead Market Movers as Indian Equities See Volatile Trading Robert Kiyosaki Predicts Gold at 10000 and Silver 200 Warns of Imminent Stock Market Crash AI Infrastructure and Energy Stocks Outperform Nvidia Market Data Suggests Doubling Returns DAWN Q4 2025 Earnings Miss on EPS as PreRevenue Biotech Invests in Pipeline BLMN Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency PVL Q1 2023 Earnings Royalty Trust Delivers 013 Per Unit Stock Reacts Positively CURB Q1 2026 Earnings EPS Misses Estimates but Stock Moves Higher MBRX Q1 2026 Earnings EPS Misses Estimates Widely Stock Rises on Speculative Momentum MGNX Q1 2026 Earnings NarrowerThanExpected Loss as Cost Discipline Offsets Zero Revenue FIGS Inc Edges Higher as Stock Approaches Resistance Zone Immatics IMTX Surges 5 Breaking Resistance or Facing a Ceiling Euronet Worldwide EEFT Gains 128 as Stock Approaches Key Resistance at 7367 NiSource NI Edges Higher as Utility Stock Holds Steady Above Support First Business Financial Services FBIZ Edges Higher Amid Steady Trading Jim Cramer Urges Focus on Future Upside in AI Stocks Highlights Corning Example SXI Q1 2026 Earnings Modest EPS Miss Amidst Solid Operational Performance Malibu Boats MBUU Rises 283 as Volume Picks Up Resistance at 2977 in Focus WD40 Company WDFC Dips 105 as Shares Approach Key Support Level Eve Holding Inc EVEX Edges Higher as Shares Test Key Resistance at 32 Intercontinental Exchange ICE Edges Higher Amid Positive Volume Trends Biote Corp BTMD Gains 391 as Stock Approaches Key Resistance at 21 Cousins Properties CUZ Holds Steady as Support Level Attracts Buyers Key Technical Range in Focus OMS Energy Technologies OMSE Holds Near Support After Modest Gains Consolidation Phase in Focus Praxis Precision Medicines PRAX Holds Near Resistance After Slight Pullback